Huiyan Zeng Selected Research

Melanoma (Melanoma, Malignant)

1/2020

Orphan nuclear receptor TR3/Nur77 biologics inhibit tumor growth by targeting angiogenesis and tumor cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Huiyan Zeng Research Topics

Disease

14	Neoplasms (Cancer) 01/2022 - 02/2003
9	Inflammation (Inflammations) 03/2013 - 12/2002
6	Down Syndrome (Down's Syndrome) 01/2022 - 11/2006
4	Pathologic Neovascularization 12/2008 - 03/2006
3	Colitis 02/2011 - 10/2004
2	Neoplasm Metastasis (Metastasis) 01/2022 - 06/2017
2	Pain (Aches) 11/2020 - 09/2020
2	Type 2 Diabetes Mellitus (MODY) 01/2020 - 07/2014
2	Sepsis (Septicemia) 01/2020 - 01/2019
2	Carcinogenesis 08/2017 - 06/2017
1	Non-alcoholic Fatty Liver Disease 05/2022
1	Peripheral Nervous System Diseases (PNS Diseases) 11/2020
1	Neuralgia (Stump Neuralgia) 11/2020
1	Albuminuria 01/2020
1	Diabetic Nephropathies (Diabetic Nephropathy) 01/2020
1	Melanoma (Melanoma, Malignant) 01/2020
1	Endotoxemia 01/2019
1	Thrombosis (Thrombus) 06/2017
1	Liver Neoplasms (Liver Cancer) 06/2017
1	Infections 08/2012
1	Hypoxia (Hypoxemia) 08/2009
1	Colonic Neoplasms (Colon Cancer) 04/2007
1	Adenocarcinoma 02/2003
1	Pancreatic Neoplasms (Pancreatic Cancer) 02/2003
1	Astrocytoma (Pilocytic Astrocytoma) 12/2002

Drug/Important Bio-Agent (IBA)

14	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 02/2003
7	Protein Isoforms (Isoforms)IBA 01/2022 - 12/2003
6	Histamine (Histamine Dihydrochloride)FDA Link 01/2022 - 03/2013
5	Member 1 Group A Nuclear Receptor Subfamily 4IBA 01/2020 - 10/2014
5	NeurotensinIBA 02/2011 - 06/2003
5	NeuropeptidesIBA 02/2011 - 12/2002
4	Proteins (Proteins, Gene)FDA Link 01/2020 - 06/2017
3	matrigelIBA 11/2021 - 12/2008
3	Serotonin (5 Hydroxytryptamine)IBA 01/2020 - 03/2013
3	Interleukin-8 (Interleukin 8)IBA 02/2011 - 12/2002
3	NF-kappa B (NF-kB)IBA 04/2006 - 12/2002
2	Complementary DNA (cDNA)IBA 01/2022 - 01/2020
2	Messenger RNA (mRNA)IBA 01/2020 - 04/2006
2	IntegrinsIBA 01/2019 - 01/2019
2	Glucose (Dextrose)FDA LinkGeneric 07/2014 - 08/2012
2	Clostridium difficile tcdA proteinIBA 02/2011 - 10/2004
2	ErbB Receptors (EGF Receptor)IBA 02/2011 - 04/2007
2	InterleukinsIBA 06/2005 - 12/2002
1	ginsenoside RfIBA 05/2022
1	Therapeutic UsesIBA 05/2022
1	Biological ProductsIBA 05/2022
1	TriterpenesIBA 05/2022
1	Cadherins (E-Cadherin)IBA 01/2022
1	CarcinogensIBA 01/2022
1	cadherin 5IBA 11/2021
1	NAD (NADH)IBA 11/2020
1	Biomarkers (Surrogate Marker)IBA 09/2020
1	Glucagon-Like Peptide-1 ReceptorIBA 01/2020
1	Exenatide (Byetta)FDA Link 01/2020
1	Insulin Glargine (Lantus)FDA Link 01/2020
1	LipopolysaccharidesIBA 01/2019
1	Blood Glucose (Blood Sugar)IBA 07/2014
1	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 06/2011
1	Dextran SulfateIBA 02/2011
1	Angiogenesis InhibitorsIBA 08/2009
1	Hypoxia-Inducible Factor 1IBA 08/2009
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 08/2009
1	Complement System Proteins (Complement)IBA 08/2009
1	CalcineurinIBA 11/2006
1	Sulfates (Sulfates, Inorganic)IBA 04/2006
1	GhrelinIBA 04/2006
1	Orphan Nuclear ReceptorsIBA 03/2006
1	Transcription Factors (Transcription Factor)IBA 03/2006
1	Neuropilin-1IBA 12/2003
1	Insulin-Like Growth Factor I (IGF-1)IBA 02/2003
1	IGF Type 1 Receptor (IGF 1 Receptor)IBA 02/2003
1	Insulin-Like PeptidesIBA 02/2003
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 02/2003
1	p38 Mitogen-Activated Protein KinasesIBA 12/2002
1	Substance PIBA 12/2002
1	Mitogen-Activated Protein KinasesIBA 12/2002
1	Neurokinin-1 Receptors (Neurokinin 1 Receptor)IBA 12/2002

Therapy/Procedure

3	Therapeutics 08/2017 - 08/2009
1	Transcranial Magnetic Stimulation 09/2020
1	Ligation 01/2019
1	Punctures 01/2019